<PAGE>
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Tenet Healthcare Corporation
(formerly National Medical Enterprises, Inc.)
(Name of Issuer)
Common Stock, $0.075 par value per share
(Title of Class of Securities)
88033G-10-0
(CUSIP Number)
Harold S. Handelsman, Esq.
200 West Madison Street
Chicago, Illinois 60606
(312) 750-8102
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
February 13, 1996
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(b)(3) or (4), check the following
box [ ].
Check the following box if a fee is being paid with the statement [ ].
(A fee is not required only if the reporting person: (1) has a previous
statement on file reporting beneficial ownership of more than five percent of
the class of securities described in Item 1; and (2) has filed no amendment
subsequent thereto reporting beneficial ownership of five percent or less of
such class.) (See Rule 13d-7.)
NOTE: Six copies of this statement, including all exhibits, should be
filed with the Commission. See Rule 13d-1(a) for other parties to whom copies
are to be sent.
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder on this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
(continued on following pages)
Page 1 of 4 Pages<PAGE>
<PAGE>
1. NAME OF REPORTING PERSON
GKH Investments, L.P.
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
3. SEC USE ONLY
4. SOURCE OF FUNDS
OO (See Item 3)
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER 7. SOLE VOTING POWER
OF -0-
SHARES
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY -0-
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON -0-
WITH
10. SHARED DISPOSITIVE POWER
-0-
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
-0-
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[X]
The aggregate amount set forth in row 11 excludes 392,530 shares
of Common Stock (.20% of the outstanding shares) owned by GKH
Private Limited. See Items 3 and 6 of the initial Schedule 13D.
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
14. TYPE OF REPORTING PERSON
PN
Page 2 of 4 pages<PAGE>
<PAGE>
ONLY THOSE ITEMS AMENDED ARE REPORTED HEREIN
- --------------------------------------------
THIS AMENDMENT NO. 1 AMENDS THE INITIAL SCHEDULE 13D RELATING TO COMMON STOCK
OF NATIONAL MEDICAL ENTERPRISES, INC., A NEVADA CORPORATION AND PREDECESSOR OF
TENET HEALTHCARE CORPORATION, DATED MARCH 10, 1995 (THE "INITIAL SCHEDULE
13D"). CAPITALIZED TERMS NOT OTHERWISE DEFINED HEREIN SHALL HAVE THE MEANINGS
ASCRIBED TO THEM IN THE INITIAL SCHEDULE 13D.
Item 1. Security and Issuer
-------------------
This Amendment No. 1 to Schedule 13D relates to the Common Stock, $0.075
par value per share (the "Common Stock"), of Tenet Healthcare Corporation (the
"Company"), the principal executive offices of which are located at
2700 Colorado Avenue, Santa Monica, California 90404.
Item 2. Interest in Securities of the Issuer
------------------------------------
(a) - (b) As of February 13, 1996, GKH, the General Partner of the
Fund, determined it to be in the best interest of the
limited partners of the Fund to distribute the 10,382,050
shares of Common Stock then held by the Fund to the
partners of the Fund. Accordingly, as of such date, (i)
each of the Fund's partners became the beneficial owner of
their pro rata share of the Common Stock previously held by
the Fund, and (ii) the Fund no longer beneficially owned
shares of Common Stock or had any voting or dispositive
power with respect thereto. No partner of the Fund
received 5% or more of the Company's outstanding Common
Stock as a result of the Fund's distribution.
(c) Other than as described above, during the past 60 days,
neither the Fund nor, to the best knowledge of the Fund,
any of the persons identified in Appendix A to the initial
Schedule 13D, have effected any other transactions in the
Common Stock.
(d) As of February 13, 1996, each of the Fund's partners became
the beneficial owner of their pro rata share of the Common
Stock previously held by the Fund. No partner of the Fund
received 5% or more of the Company's outstanding Common
Stock as a result of the Fund's distribution.
(e) February 13, 1996.
Page 3 of 4 pages<PAGE>
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: February 20, 1996.
GKH INVESTMENTS, L.P., a Delaware limited
partnership
By: GKH PARTNERS, L.P., its
general partner
By: HGM ASSOCIATES LIMITED
PARTNERSHIP, a general partner
By: HGM CORPORATION, its general
partner
By: ________________________________
Harold S. Handelsman,
Vice President
Page 4 of 4 pages <PAGE>
